Scientific paper - Original scientific paper
Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients
Blood Cells, Molecules, and Diseases, 72 (2018); 14-16. https://doi.org/10.1016/j.bcmd.2018.06.001

Lucijanić, Marko; Čičić, David; Štoos-Veić, Tajana; Pejša, Vlatko; Rahelić, Dario; Lucijanić, Tomo; Vasilj, Tamara; Ivić, Marija; Sedinić, Martina; Kušec, Rajko

Cite this document

Lucijanić, M., Čičić, D., Štoos Veić, T., Pejša, V., Rahelić, D., Lucijanić, T. ... Kušec, R. (2018). Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients. Blood Cells, Molecules, and Diseases, 72., 14-16. doi: 10.1016/j.bcmd.2018.06.001

Lucijanić, Marko, et al. "Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients." Blood Cells, Molecules, and Diseases, vol. 72, 2018, pp. 14-16. https://doi.org/10.1016/j.bcmd.2018.06.001

Lucijanić, Marko, David Čičić, Tajana Štoos Veić, Vlatko Pejša, Dario Rahelić, Tomo Lucijanić, Tamara Vasilj, Marija Ivić, Martina Sedinić and Rajko Kušec. "Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients." Blood Cells, Molecules, and Diseases 72 (2018): 14-16. https://doi.org/10.1016/j.bcmd.2018.06.001

Lucijanić, M., et al. (2018) 'Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients', Blood Cells, Molecules, and Diseases, 72, pp. 14-16. doi: 10.1016/j.bcmd.2018.06.001

Lucijanić M, Čičić D, Štoos Veić T, Pejša V, Rahelić D, Lucijanić T, and sur.. Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients. Blood Cells, Molecules, and Diseases [Internet]. 2018 September [cited 2024 December 03];72:14-16. doi: 10.1016/j.bcmd.2018.06.001

M. Lucijanić, et al., "Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients", Blood Cells, Molecules, and Diseases, vol. 72, pp. 14-16, September 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:917549. [Accessed: 03 December 2024]

Please login to the repository to save this object to your list.